Lithuania VVKT · July 22, 2026

Supply resumption notice: Delstrigo, Paclitaxel EBEWE, Cerucal, Ubistesin, Ubistesin forte, Mepivastesin and Rivaroxaban STADA

Original title: Dėl vaistinių preparatų Delstrigo, Paclitaxel EBEWE, Cerucal, Ubistesin, Ubistesin forte, Mepivastesin ir Rivaroxaban STADA tiekimo atnaujinimo

Supply resumption announced for seven named medicinal products following prior shortage.

Low obligation Product class Pharmaceuticals Lithuania Supply shortages

Informuojame, kad atnaujintas vaistinių preparatų Delstrigo (Doravirinas/Lamivudinas/Tenofoviro dizoproksilis) 100 mg/ 300 mg/ 245 mg plėvele dengtos tabletės N30, Paclitaxel EBEWE (Paklitakselis) 6 mg/ml koncentratas infuziniam tirpalui 50 ml N1, Cerucal …

Read the official source ↗

Published by Lithuania VVKT. HealthSignal links to the original document; the summary above is extracted from the source text.